Rocket One Inc. CEO and Top Insiders Buy Massive Options as Company Rebrands to Orbital‑Tech Powerhouse, Signaling Bold Shift from Biopharma to AI‑Enabled Space Computing
Insider options pile up as Rocket One pivots from biotech to orbital‑tech, aligning leadership incentives with AI‑enabled chip strategy and promising a 12‑18‑month profitability outlook.
3 minutes to read